152 related articles for article (PubMed ID: 2241600)
1. Selective removal of anti-acetylcholine receptor antibodies and IgG in vitro with an immunoadsorbent containing immobilized sulfathiazole.
Yamamoto Y; Sameshima T; Akaike T
Artif Organs; 1990 Oct; 14(5):334-41. PubMed ID: 2241600
[TBL] [Abstract][Full Text] [Related]
2. Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis.
Takamori M; Ide Y
Transfus Sci; 1996 Sep; 17(3):445-53. PubMed ID: 10163553
[TBL] [Abstract][Full Text] [Related]
3. Specific immunoadsorbent for myasthenia gravis treatment: development of synthetic peptide designed to remove antiacetylcholine receptor antibody.
Miyahara T; Oka K; Nakaji S
Ther Apher; 1998 Aug; 2(3):246-8. PubMed ID: 10227779
[TBL] [Abstract][Full Text] [Related]
4. Adsorption column for myasthenia gravis treatment: Medisorba MG-50.
Nakaji S; Hayashi N
Ther Apher Dial; 2003 Feb; 7(1):78-84. PubMed ID: 12921120
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
Somnier FE; Langvad E
J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
[TBL] [Abstract][Full Text] [Related]
6. Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum.
Guo CY; Li ZY; Xu MQ; Yuan JM
J Immunol Methods; 2005 Aug; 303(1-2):142-7. PubMed ID: 16040047
[TBL] [Abstract][Full Text] [Related]
7. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor.
Takamori M; Maruta T
Ther Apher; 2001 Oct; 5(5):340-50. PubMed ID: 11778918
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific apheresis of autoantibodies in myasthenia gravis.
Lazaridis K; Zisimopoulou P; Lagoumintzis G; Skriapa L; Trakas N; Evangelakou P; Kanelopoulos I; Grapsa E; Poulas K; Tzartos S
Ann N Y Acad Sci; 2012 Dec; 1275():7-12. PubMed ID: 23278571
[TBL] [Abstract][Full Text] [Related]
10. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
Sun C; Meng F; Li Y; Jin Q; Li H; Li F
Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):99-102. PubMed ID: 20196680
[TBL] [Abstract][Full Text] [Related]
12. Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis.
Lang B; Vincent A; Newsom-Davis J
J Immunol Methods; 1982; 51(3):371-81. PubMed ID: 7108235
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
Whiting PJ; Vincent A; Newsom-Davis J
J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
[TBL] [Abstract][Full Text] [Related]
14. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of experimental autoimmune myasthenia gravis rats by blood purification treatment using 4-mercaptoethylpyridine-based adsorbent.
Ren J; Bai Y; Hao L; Dong Y; Pi Z; Jia L
J Biomed Mater Res A; 2011 Sep; 98(4):589-95. PubMed ID: 21721115
[TBL] [Abstract][Full Text] [Related]
16. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
17. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
[TBL] [Abstract][Full Text] [Related]
18. Future therapeutic strategies in autoimmune myasthenia gravis.
Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis therapy: immunoadsorbent may eliminate need for plasma products.
Sawada K; Malchesky PS; Koo AP; Mitsumoto H
Cleve Clin J Med; 1993; 60(1):60-4. PubMed ID: 8443936
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures.
Padberg F; Matsuda M; Fenk R; Patenge N; Kubuschok B; Hohlfeld R; Wekerle H; Spuler S
Eur J Immunol; 1999 Nov; 29(11):3538-48. PubMed ID: 10556808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
